A Pilot Study of Discontinuous, Insulin-Like Growth Factor 1–Dosing Growth Hormone Treatment in Young Children with FGFR3 N540K-Mutated Hypochondroplasia-Reference-Cited by-同舟云学术

A Pilot Study of Discontinuous, Insulin-Like Growth Factor 1–Dosing Growth Hormone Treatment in Young Children with FGFR3 N540K-Mutated Hypochondroplasia

Published:2012-05 Issue:5 Volume:160 Page:849-853
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Rothenbuhler Anya,Linglart Agnès,Piquard Catherine,Bougnères Pierre

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference41 articles.

1. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia;Bellus;Nat Genet,1995

2. A common FGFR3 gene mutation in hypochondroplasia;Prinos;Hum Mol Genet,1995

3. Clinical and genetic heterogeneity of hypochondroplasia;Rousseau;J Med Genet,1996

4. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia;Heuertz;Eur J Hum Genet,2006

5. Analysis of the FGFR3 gene in Japanese patients with achondroplasia and hypochondroplasia;Katsumata;Endocr J,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth reference charts for children with hypochondroplasia;American Journal of Medical Genetics Part A;2023-10-09

2. Clinical Manifestations and Outcomes of 20 Korean Hypochondroplasia Patients with the FGFR3 N540K variant;Experimental and Clinical Endocrinology & Diabetes;2022-11-28

3. Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia;Clinical Endocrinology;2016-02-25

4. FGFR3/fibroblast growth factor receptor 3 inhibits autophagy through decreasing the ATG12–ATG5 conjugate, leading to the delay of cartilage development in achondroplasia;Autophagy;2015-11-02

5. Height outcome of short children with hypochondroplasia after recombinant human growth hormone treatment: a meta-analysis;Pharmacogenomics;2015-11